Posted on

GDMeds Look Deep: COVID-19 vaccines – Effectiveness and Safety Details

Posted on

As a pharmacy and the distributor of anti-COVID-19 medicines, e.g. Remdesivir, Alltera, etc. GDMeds works on the frontline, and wish could support most people get necessary medicines and overcome this pandemic. As the pandemic rages on, it’s increasingly clear that widespread vaccination is essential to help contain it. Physical distancing, universal face coverings, and frequent…

Read more

Posted on

Breast Cancer Drugs May Severely Inflame Lungs, FDA Warns

Posted on

The US Food and Drug Administration (FDA) issued a warning today that the commonly prescribed breast cancer therapies known as cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors may cause rare but severe inflammation of the lungs. The related products include palbociclib (Ibrance, Pfizer), ribociclib (Kisqali, Novartis), and abemaciclib (Verzenio, Eli Lilly), which are approved for use in patients with hormone receptor (HR)-positive, human epidermal…

Read more

Posted on

Immunotherapy Plus Targeted Drug in First-Line Kidney Cancer

Posted on

  Adding immunotherapy to a targeted agent significantly improved progression-free survival (PFS) when compared with a targeted agent alone in the first-line treatment of advanced renal cell carcinoma (RCC), suggests interim results from the JAVELIN Renal 101 trial. The combination therapy, comprised of the anti-programmed cell death ligand 1 (PD-L1) drug avelumab (Bavencio, EMD Serono) and the…

Read more